DLDavid T S Lin

David T S Lin

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


David T S Lin has a total of 27 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    RAMEN: Dissecting individual, additive and interactive gene-environment contributions to DNA methylome variability in cord blood

    by Erick I. Navarro-Delgado, Darina Czamara, Karlie Edwards, Maggie P. Fu, Sarah M. Merrill, Chaini Konwar, Julie L. MacIsaac, David T.S. Lin, Piush Mandhane, Elinor Simons, et al.

    Genetic variation and environmental exposures are amongst the main factors associated with inter-individual DNA methylation variability. However, the prevalence and genomic context of individual, additive, and interactive gene-environment effects remains unclear. We present RAMEN, an R package that dissects genome-exposome contributions to microarray Variably Methylated Loci using machine learning and statistical techniques. Analyzing cord blood samples from CHILD and PREDO (overall n = 1662), we identify genetic variants as key contributors to DNA methylation variability, usually in additive and interactive combinations with the environment. We provide a detailed catalogue of cord blood Variably Methylated Loci and the gene-environment contribution to their variability.


  • Open Access

    Alpha-synuclein overexpression induces epigenomic dysregulation of glutamate signaling and locomotor pathways

    by Samantha L Schaffner, Zinah Wassouf, Diana F Lazaro, Mary Xylaki, Nicole Gladish, David T S Lin, Julia MacIsaac, Katia Ramadori, Thomas Hentrich, Julia M Schulze-Hentrich, et al.

    Parkinson’s disease (PD) is a neurological disorder with complex interindividual etiology that is becoming increasingly prevalent worldwide. Elevated alpha-synuclein levels can increase risk of PD and may influence epigenetic regulation of PD pathways. Here, we report genome-wide DNA methylation and hydroxymethylation alterations associated with overexpression of two PD-linked alpha-synuclein variants (wild-type and A30P) in LUHMES cells differentiated to dopaminergic neurons. Alpha-synuclein altered DNA methylation at thousands of CpGs and DNA hydroxymethylation at hundreds of CpGs in both genotypes, primarily in locomotor behavior and glutamate signaling pathway genes. In some cases, epigenetic changes were associated with transcription. SMITE network analysis incorporating H3K4me1 ChIP-seq to score DNA methylation and hydroxymethylation changes across promoters, enhancers, and gene bodies confirmed epigenetic and transcriptional deregulation of glutamate signaling modules in both genotypes. Our results identify distinct and shared impacts of alpha-synuclein variants on the epigenome, and associate alpha-synuclein with the epigenetic etiology of PD.